211 related articles for article (PubMed ID: 31244304)
1. Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
Charoonwatana T; Boonlikit S; Yanaranop M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1809-1815. PubMed ID: 31244304
[TBL] [Abstract][Full Text] [Related]
2. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
3. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision.
Lukic A; Rossi S; Frega A; Ruscito I; Bianchi P; Nobili F; Caserta D; Vecchione A
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1261-1273. PubMed ID: 33629296
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of p16
Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
Pacchiarotti A; Ferrari F; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
Int J Cancer; 2014 Feb; 134(4):897-904. PubMed ID: 23913416
[TBL] [Abstract][Full Text] [Related]
7. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
8. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.
Mills AM; Paquette C; Castle PE; Stoler MH
Am J Surg Pathol; 2015 May; 39(5):611-7. PubMed ID: 25602791
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
12. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization.
Cardoso FA; Campaner AB; Silva MA
APMIS; 2014 Mar; 122(3):192-9. PubMed ID: 23763281
[TBL] [Abstract][Full Text] [Related]
15. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
17. TOP2A/MCM2, p16
Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
Guo M; Warriage I; Mutyala B; Patel S; Lin E; Gong Y; Sneige N
Diagn Cytopathol; 2011 Jul; 39(7):482-8. PubMed ID: 20607682
[TBL] [Abstract][Full Text] [Related]
19. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
Mandal R; Ghosh I; Banerjee D; Mittal S; Muwonge R; Roy C; Panda C; Vernekar M; Frappart L; Basu P
Int J Gynecol Pathol; 2020 Jul; 39(4):384-390. PubMed ID: 32515923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]